Muscular Dystrophy Association’s Venture Philanthropy Program Announces Investment in Non-viral Gene Therapy
January 25, 2023 09:00 ET
|
Muscular Dystrophy Association
New York, NY, Jan. 25, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announces a $650,000 investment in Myosana Therapeutics via its MDA Venture Philanthropy (MVP) program....